Modern Approaches to Rectal Cancer: Integrating Endoscopic, Surgical, and Oncological Care
Open Access
Abstract
Rectal cancer remains a significant clinical challenge due to its complex anatomy and the critical need to balance oncological radicality with functional preservation. Multimodal treatment strategies, including neoadjuvant therapy, advanced endoscopic techniques, and precise surgical approaches, have evolved to optimize patient outcomes. Neoadjuvant chemoradiotherapy improves resectability and local control in locally advanced tumors, while endoscopic treatment offers organ-preserving options for carefully selected early-stage cancers. Surgical resection, primarily through total mesorectal excision (TME), remains the cornerstone of curative therapy, with minimally invasive and transanal approaches enhancing precision and recovery. In advanced and recurrent cases, extended procedures such as pelvic exenteration provide potential for cure despite substantial morbidity. This review summarizes current evidence on the indications, techniques, and outcomes of neoadjuvant, endoscopic, and surgical treatments for rectal cancer, emphasizing individualized treatment planning to achieve optimal oncological and functional results.Keywords
Funding Information
- Ministry of Defence of the Czech Republic “Long Term Organization Development Plan 1011”—Clinical Branches II of the Military Faculty of Medicine Hradec Kralove, University of Defence, Czech Republic
- Charles University research program “Cooperatio” research area Surgical Disciplines
This publication has 74 references indexed in Scilit:
- Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trialThe Lancet Oncology, 2015
- Transanal Total Mesorectal Excision for Rectal Cancer: Outcomes after 140 PatientsJournal of the American College of Surgeons, 2015
- Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trialThe Lancet Oncology, 2013
- The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International ConsensusThe Oncologist, 2012
- Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 YearsJournal of Clinical Oncology, 2012
- Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trialThe Lancet Oncology, 2012
- Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, CanadaCancer, 2011
- Prognosis of node-positive colon cancerCancer, 1991
- Clinical results of transanal endoscopic microsurgerySurgical Endoscopy, 1988
- The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?British Journal of Surgery, 1982